(Q28206098)

22 April 2017

0 references

1 reference

James Edward Mitchell

series ordinal

3

object named as

James E Mitchell

1 reference

22 April 2017

author name string

Kristine J Pederson

series ordinal

1

1 reference

22 April 2017

James L Roerig

series ordinal

2

1 reference

22 April 2017

language of work or name

English

0 references

publication date

October 2003

1 reference

Expert Opinion on Pharmacotherapy

22 April 2017

published in

1 reference

22 April 2017

volume

4

1 reference

22 April 2017

issue

10

1 reference

22 April 2017

page(s)

1659-78

0 references

1659-1678

1 reference

Mortality in anorexia nervosa

22 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Cyproheptadine in Anorexia Nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Efficacy of citalopram in anorexia nervosa: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Sertraline in the treatment of restricting anorexia nervosa: an open controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Sertraline in underweight binge eating/purging-type eating disorders: five case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Changes in weight in patients receiving a tranquilizing drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Case study: anorexia nervosa and autistic disorder in an adolescent girl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Case reports of olanzapine treatment of anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Olanzapine in the treatment of anorexia nervosa: an open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Zinc deficiency in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Phenelzine vs placebo in 50 patients with bulimia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

A double-blind trial of phenelzine in bulimia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Topiramate in the treatment of severe bulimia nervosa with comorbid mood disorders: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

A randomized secondary treatment study of women with bulimia nervosa who fail to respond to CBT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.10.1659

10.1517/EOPH.4.10.1659.22323

21 January 2018

Identifiers

DOI

0 references

10.1517/14656566.4.10.1659

1 reference